New cancer-causing toxin found in recalled blood pressure pills
(Reuters) – U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India’s Hetero Labs Ltd a day earlier, adding to…
U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug
(Reuters) – U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost versions of a drug used to treat a rare neuromuscular…
J&J becomes first drugmaker to add prices to television ads
FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo CHICAGO (Reuters) – Johnson & Johnson said on Thursday it will…
Sanofi blood disorder drug wins FDA approval
(Reuters) – The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Sanofi SA’s drug to treat a rare blood-clotting disorder in adults in combination with standard-of-care…
FDA approves cheaper Botox rival to treat frown lines
(Reuters) – An injection that makes forehead wrinkles disappear is set to rival Allergan’s Botox after U.S. regulators approved Evolus Inc’s cheaper treatment on Friday. Evolus expects Jeuveau to be…
Salmonella outbreak linked to raw turkey leaves over 200 sick across U.S.
(Reuters) – More than 200 people from across the United States have fallen ill, 84 of them hospitalized, from an ongoing salmonella outbreak linked to raw turkey products that prompted…
FDA panel backs prescribing opioid overdose reversal drug along with painkillers
(Reuters) – An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended prescribing the opioid overdose reversal drug, naloxone, along with addictive painkillers. FILE PHOTO: The drug…
BrainStorm gets FDA okay for stem cell trial in MS patients
TEL AVIV (Reuters) – BrainStorm Cell Therapeutics Inc has received approval from the U.S. Food and Drug Administration to begin a clinical trial of its experimental stem cell treatment in…
Evofem shares surge as contraceptive gel meets late-stage trial goal
(Reuters) – Shares of Evofem Biosciences Inc jumped as much as 38 percent on Monday after its birth control gel showed effectiveness in a late-stage study, bringing the first hormone-free…
E-cigarette usage nearly doubles in U.S. high-schools: survey
A young man smokes an electronic cigarette in this picture illustration taken September 14, 2018. REUTERS/Mike Blake/Illustration (Reuters) – The percentage of high school seniors who used e-cigarettes in the…